Paper4200780
An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes.
Martz E and 1 other. J Immunol, 1973. Cited by 75 papers, by iCite.
Cite this record
ConductScience Library. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes. Papers, record 4200780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4200780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphocytes | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Cells, Cultured | |
| Chromium Radioisotopes | |
| Complement System Proteins | |
| Cytotoxicity Tests, Immunologic | |
| Immune Sera | |
| Immunization | |
| Mast-Cell Sarcoma | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Peritoneal Cavity | |
| Spleen |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7027264 | Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/7027264 | PubMed |
| 6970176 | The mechanism of T-cell mediated cytotoxicity. VIII. Zeiosis corresponds to irreversible phase (programming for lysis) in steps leading to lysis. | Immunology | 1981 | https://conductscience.org/library/papers/6970176 | PubMed |
| 6773881 | Ionophore-A23187-induced cellular cytotoxicity: a cell fragment mediated process. | Immunology | 1980 | https://conductscience.org/library/papers/6773881 | PubMed |
| 6769782 | Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+. | Immunology | 1980 | https://conductscience.org/library/papers/6769782 | PubMed |
| 6155344 | Analysis of the lytic step in the herpes simplex virus antibody-dependent cellular cytotoxicity system. | Infect Immun | 1980 | https://conductscience.org/library/papers/6155344 | PubMed |
| 4359327 | Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4359327 | PubMed |
| 2118476 | Differential requirement for protein synthesis in cytolysis mediated by class I and class II MHC-restricted cytotoxic T cells. | Immunology | 1990 | https://conductscience.org/library/papers/2118476 | PubMed |
| 955681 | Lectin-dependent neutrophil-mediated cytotoxicity. II. Possible mechanisms. | Immunology | 1976 | https://conductscience.org/library/papers/955681 | PubMed |
| 821684 | Cytotoxic activity of human lymphocyte plasma membranes. | Clin Exp Immunol | 1976 | https://conductscience.org/library/papers/821684 | PubMed |
| 409663 | Increased cell-mediated lysis of chicken erythrocytes following the addition of metabolic inhibitors. | Immunology | 1977 | https://conductscience.org/library/papers/409663 | PubMed |
| 308086 | Requirement for hexose, unrelated to energy provision, in T-cell-mediated cytolysis at the lethal hit stage. | J Exp Med | 1978 | https://conductscience.org/library/papers/308086 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4200780
GET https://conductscience.org/api/papers/v1/4200780/authors